gyki 53655 has been researched along with willardiine in 1 studies
| Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (willardiine) | Trials (willardiine) | Recent Studies (post-2010) (willardiine) |
|---|---|---|---|---|---|
| 111 | 0 | 22 | 43 | 0 | 10 |
| Protein | Taxonomy | gyki 53655 (IC50) | willardiine (IC50) |
|---|---|---|---|
| Chain A, glutamate receptor 2 | Rattus norvegicus (Norway rat) | 4.76 | |
| Chain A, glutamate receptor 2 | Rattus norvegicus (Norway rat) | 4.76 | |
| Chain A, glutamate receptor 2 | Rattus norvegicus (Norway rat) | 4.76 | |
| Chain A, glutamate receptor 2 | Rattus norvegicus (Norway rat) | 4.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jane, DE; More, JC; Troop, HM | 1 |
1 other study(ies) available for gyki 53655 and willardiine
| Article | Year |
|---|---|
The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres.
Topics: Alanine; Animals; Animals, Newborn; Benzodiazepines; Benzyl Compounds; Dose-Response Relationship, Drug; Evoked Potentials; Excitatory Amino Acid Antagonists; Motor Neurons; Nerve Fibers; Pyrimidinones; Quinoxalines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Spinal Nerve Roots; Time Factors; Uracil | 2002 |